We are live on ! Find out more

602 hedge funds and large institutions have $8.52B invested in Sanofi in 2020 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 182 increasing their positions, 220 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $46.5M | Put options by funds: $25.8M

66% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 56

5% more funds holding

Funds holding: 573602 (+29)

0.12% more ownership

Funds ownership: 13.79%13.9% (+0.12%)

2% less capital invested

Capital invested by funds: $8.71B → $8.52B (-$191M)

17% less repeat investments, than reductions

Existing positions increased: 182 | Existing positions reduced: 220

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
602
Holders Change
+29
Holders Change %
+5.06%
% of All Funds
10.65%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
93
Increased
182
Reduced
220
Closed
56
Calls
$46.5M
Puts
$25.8M
Net Calls
+$20.7M
Net Calls Change
-$36K
Name Holding Trade Value Shares
Change
Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$1.94B +$31.1M +631,476 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$913M +$27.6M +558,819 +3%
Fisher Asset Management
3
Fisher Asset Management
Washington
$885M -$20.2M -409,356 -2%
BlackRock
4
BlackRock
New York
$668M +$15.5M +314,656 +2%
Bank of America
5
Bank of America
North Carolina
$414M -$1.55M -31,464 -0.4%
Invesco
6
Invesco
Georgia
$269M -$55.4M -1,123,140 -17%
Hotchkis & Wiley Capital Management
7
Hotchkis & Wiley Capital Management
California
$262M +$92.4M +1,873,200 +53%
Morgan Stanley
8
Morgan Stanley
New York
$187M +$11.5M +232,277 +6%
Lazard Asset Management
9
Lazard Asset Management
New York
$147M -$3.44M -69,692 -2%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$146M +$78.6M +1,593,595 +113%
Macquarie Group
11
Macquarie Group
Australia
$137M -$3.93M -79,694 -3%
PPA
12
Parametric Portfolio Associates
Washington
$124M +$22.8M +462,288 +22%
Northern Trust
13
Northern Trust
Illinois
$113M +$586K +11,879 +0.5%
RG
14
Redmile Group
California
$96.4M +$11.9M +241,642 +14%
Primecap Management
15
Primecap Management
California
$82.8M -$1.9M -38,610 -2%
Wells Fargo
16
Wells Fargo
California
$81.6M -$4.72M -95,788 -5%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$72.6M +$396K +8,023 +0.5%
Goldman Sachs
18
Goldman Sachs
New York
$70.7M +$6.38M +129,434 +10%
Artisan Partners
19
Artisan Partners
Wisconsin
$67M -$3.58M -72,620 -5%
HCM
20
Hamlin Capital Management
New York
$66.3M +$8.82M +178,816 +15%
First Trust Advisors
21
First Trust Advisors
Illinois
$55.7M +$5.57M +112,907 +11%
MIP
22
Mondrian Investment Partners
United Kingdom
$52M -$738K -14,960 -1%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$51.4M -$321K -6,500 -0.6%
Natixis Advisors
24
Natixis Advisors
Massachusetts
$50.2M +$1.36M +27,513 +3%
CI
25
Cambiar Investors
Colorado
$50.1M -$6.53M -132,348 -11%

SNY Hedge Fund Activity: Q4 2020 in Review

602 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2020, worth a combined $8.52B — down 2.2% from $8.71B a quarter earlier.

Buyers outnumbered sellers: 93 funds opened new SNY positions and 56 closed out — a net gain of 37 holders — while 182 added to existing stakes and 220 trimmed.

The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $92.4M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $56.2M sold.

  • 602 institutional investors held Sanofi (SNY) as of Q4 2020, up from 573 in Q3 2020.
  • Funds reported $8.52B of Sanofi stock for Q4 2020, down 2.2% quarter-over-quarter.
  • 93 funds opened new Sanofi positions in Q4 2020 and 56 closed out, a net change of +37 holders.
  • The largest Sanofi buyer in Q4 2020 was Hotchkis & Wiley Capital Management, an estimated $92.4M added.
  • The largest Sanofi seller in Q4 2020 was Sphera Funds Management, an estimated $56.2M sold.

Based on aggregated 13F filings for Q4 2020.